n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and pd 150606

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with pd 150606 in 1 studies

Compound Research Comparison

Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)	Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)	Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)	Studies (pd 150606)	Trials (pd 150606)	Recent Studies (post-2010) (pd 150606)
79	1	16	88	0	40

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pollack, JR; Sugimoto, JT; Witt, RC	1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and pd 150606

Article	Year
Differential effects of calpain inhibitors on hypertrophy of cardiomyocytes. Molecular and cellular biochemistry, 2003, Volume: 251, Issue:1-2 Topics: Acrylates; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Calpain; Cardiomegaly; Cells, Cultured; Cysteine Proteinase Inhibitors; Glycoproteins; Heart Ventricles; Leucine; Myocytes, Cardiac; Phenylephrine; Rats; Time Factors; Ventricular Function, Left	2003

Article

Year

Differential effects of calpain inhibitors on hypertrophy of cardiomyocytes.

Molecular and cellular biochemistry, 2003, Volume: 251, Issue:1-2

Topics: Acrylates; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Calpain; Cardiomegaly; Cells, Cultured; Cysteine Proteinase Inhibitors; Glycoproteins; Heart Ventricles; Leucine; Myocytes, Cardiac; Phenylephrine; Rats; Time Factors; Ventricular Function, Left

2003